Back to company

LICA PHARMACEUTICALS ApS: Financial statements 2025

CVR: 25332520

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. That is an increase of 70.9% compared with the year before. Equity amounted to DKK 24,221,286. The solvency ratio was 98.9%. The company had 1 employee in the financial year.

Gross Profit
359,449 kr.
Profit/Loss
450,710 kr.
Equity
24,221,286 kr.
Total Assets
24,482,608 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-359 t.451 t.24.2 mio.1
2024-210 t.1.4 mio.23.8 mio.1
2023-234 t.1.7 mio.22.4 mio.1
2022-313 t.-1.5 mio.20.6 mio.1
2021-371 t.2.6 mio.22.2 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like LICA PHARMACEUTICALS ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

LICA PHARMACEUTICALS ApS: The 2024 annual report is outMay 10, 2025

LICA PHARMACEUTICALS ApS has published its annual report for 2024. Gross profit came to DKK 210,297, and the net result was DKK 1,406,816.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.